Deep Learning for Predicting Enhancing Lesions in Multiple Sclerosis from Noncontrast MRI.
暂无分享,去创建一个
Refaat E Gabr | Ponnada A Narayana | Ivan Coronado | Jerry S Wolinsky | Sheeba J Sujit | Fred D Lublin | Sheeba J. Sujit | P. Narayana | F. Lublin | J. Wolinsky | R. Gabr | Ivan Coronado
[1] Refaat E Gabr,et al. Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale study , 2020, Multiple sclerosis.
[2] Yang Yang,et al. Glioma Grading on Conventional MR Images: A Deep Learning Study With Transfer Learning , 2018, Front. Neurosci..
[3] Hanzhang Lu,et al. Non‐contrast MR imaging of blood‐brain barrier permeability to water , 2018, Magnetic resonance in medicine.
[4] J. Pauly,et al. Deep learning enables reduced gadolinium dose for contrast‐enhanced brain MRI , 2018, Journal of magnetic resonance imaging : JMRI.
[5] D. Maintz,et al. Fully automated detection and segmentation of meningiomas using deep learning on routine multiparametric MRI , 2018, European Radiology.
[6] Taku Komura,et al. Segmentation of white matter hyperintensities using convolutional neural networks with global spatial information in routine clinical brain MRI with none or mild vascular pathology , 2018, Comput. Medical Imaging Graph..
[7] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[8] E. Kanal. Gadolinium-based Contrast Agents: The Plot Thickens. , 2017, Radiology.
[9] Atsuto Maki,et al. A systematic study of the class imbalance problem in convolutional neural networks , 2017, Neural Networks.
[10] J. Pluim,et al. Evaluation of a deep learning approach for the segmentation of brain tissues and white matter hyperintensities of presumed vascular origin in MRI , 2017, NeuroImage: Clinical.
[11] À. Rovira,et al. Consensus statement on the use of gadolinium for magnetic resonance imaging (MRI) used in the diagnosis and follow-up of patients with multiple sclerosis (MS) , 2017, Journal of the Neurological Sciences.
[12] Tyler J. Fraum,et al. Gadolinium‐based contrast agents: A comprehensive risk assessment , 2017, Journal of magnetic resonance imaging : JMRI.
[13] Fernando Calamante,et al. Gadolinium deposition in the brain: summary of evidence and recommendations , 2017, The Lancet Neurology.
[14] D. Kallmes,et al. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates. , 2017, Radiology.
[15] Yuan Yu,et al. TensorFlow: A system for large-scale machine learning , 2016, OSDI.
[16] Nicolas Michoux,et al. Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions , 2015, PloS one.
[17] Jian Sun,et al. Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[18] Khader M Hasan,et al. Effect of in‐painting on cortical thickness measurements in multiple sclerosis: A large cohort study , 2015, Human brain mapping.
[19] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[20] F. Jacques. Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.
[21] V. Dousset,et al. MS Lesions Are Better Detected with 3D T1 Gradient-Echo Than with 2D T1 Spin-Echo Gadolinium-Enhanced Imaging at 3T , 2015, American Journal of Neuroradiology.
[22] P. Narayana,et al. Regional Gray Matter Atrophy in Relapsing Remitting Multiple Sclerosis: Baseline Analysis of Multi-Center Data , 2015, Multiple sclerosis and related disorders.
[23] Dumitru Erhan,et al. Going deeper with convolutions , 2014, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[24] Ponnada A. Narayana,et al. Effect of Intrinsic and Extrinsic Factors on Global and Regional Cortical Thickness , 2014, PloS one.
[25] Daisuke Takenaka,et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. , 2014, Radiology.
[26] Gary R Cutter,et al. Randomized study combining interferon and glatiramer acetate in multiple sclerosis , 2013, Annals of neurology.
[27] M. Tullman. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. , 2013, The American journal of managed care.
[28] Ponnada A. Narayana,et al. Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study☆ , 2012, NeuroImage: Clinical.
[29] C. Crainiceanu,et al. Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents , 2012, American Journal of Neuroradiology.
[30] Jerry S. Wolinsky,et al. The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics. , 2012, Multiple sclerosis and related disorders.
[31] D. Clifford,et al. Natalizumab-associated progressive multifocal leukoencephalopathy. , 2012 .
[32] Ponnada A Narayana,et al. Segmentation of gadolinium‐enhanced lesions on MRI in multiple sclerosis , 2007, Journal of magnetic resonance imaging : JMRI.
[33] T. Grobner. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] R. He,et al. Unified Approach for Multiple Sclerosis Lesion Segmentation on Brain MRI , 2006, Annals of Biomedical Engineering.
[35] Ponnada A. Narayana,et al. Segmentation and quantification of black holes in multiple sclerosis , 2006, NeuroImage.
[36] Guang-Zhong Yang,et al. Deep Learning for Health Informatics , 2017, IEEE Journal of Biomedical and Health Informatics.
[37] Gavriel Salomon,et al. T RANSFER OF LEARNING , 1992 .